Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Wendys Co (WEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Wendys Co — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B), while Wendys Co trades at $6.23 (market cap $1.19B). The key difference: SELLAS Life Sciences Group Inc. Common Stock is the larger of the two by market cap, and Wendys Co pays a 4.49% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | WEN | |
|---|---|---|
Market Cap | $2.27B | $1.19B |
Volume | 4,179,659 | 5,622,905 |
Sector | Health | Consumer Cyclical |
52-Week High | $15.46 | $9.33 |
52-Week Low | $1.39 | $6.10 |
Enterprise Value | $2.14B | $4.92B |
Typical Hold Time | — | 77 Days |
Dividend Yield | — | 4.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WEN trades at $6.22, up 1.8% today, but remains near multi-year lows amid bearish technical signals and fundamental pressures. The stock shows low valuation multiples (P/E 9.45, P/S 0.54) and a high ROE of 108.04%, yet faces declining net income margins (7.58% in 2025) and negative sentiment from recent franchisee bankruptcies. Earnings have consistently beaten estimates, but same-store sales declines and high debt levels ($2.66B long-term) weigh on investor confidence.
The outlook is cautious; while valuation appears cheap and dividend yield offers income, competitive pressures, shrinking sales, and leveraged balance sheet pose significant risks. Analyst consensus is 'Hold' with a $7.58 price target, suggesting limited upside without operational turnaround under new leadership.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Wendys Co
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →
